Authors/Disclosures
|
Stephan A. Mayer, MD
(Henry Ford Hospital)
|
Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care. |
|
Kelly Sullivan, PhD
(Georgia Southern University)
|
Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Joseph P. Broderick, MD, FAAN
(University of Cincinnati)
|
Dr. Broderick has received publishing royalties from a publication relating to health care. |
|
Stephen M. Davis, MD, FRACP, FAAN
(Royal Melbourne Hospital)
|
No disclosure on file |
|
Michael N. Diringer, MD
(Washington Univ/Dept Neurology)
|
No disclosure on file |
|
|
No disclosure on file |